Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients.

CONCLUSION: If confirmed in a bigger cohort of patients, analysis of percentages of minor lymphocyte subpopulations in peripheral blood of patients with RRMS prior and after +1 month of treatment might predict clinical response to fingolimod. PMID: 27080413 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27080413?dopt=Abstract

Source: CNS Neuroscience and Therapeutics - April 14, 2016 Category: Neuroscience Authors: Teniente-Serra A, Hervás JV, Quirant-Sánchez B, Mansilla MJ, Grau-López L, Ramo-Tello C, Martínez-Cáceres EM Tags: CNS Neurosci Ther Source Type: research